title: The role for estrogen receptor-alpha and prolactin receptor in sex-dependent DEN-induced liver tumorigenesis.
abstract: Mice treated neonatally with diethylnitrosamine (DEN) develop liver tumors in a male-dominant manner, reflecting the male bias in human hepatocellular carcinoma. Evidence suggests that estrogen, androgen, prolactin (PRL) and growth hormone (GH) modify liver tumorigenesis. We determined the roles of estrogen receptor-α (ERα) and prolactin receptor (PRLR) using receptor null mice, ERαKO (C57Bl/6J) and PRLR-KO (129Ola-X-C57BL/6), in the neonatal-DEN model of liver tumorigenesis. In both mouse strains, females had reduced tumorigenesis compared with males (P < 0.01), regardless of ERα or PRLR status. Tumorigenesis was not affected by ovariectomy in C57Bl/6J mice but it was increased by ovariectomy in the mixed strain, 129Ola-X-C57BL/6, regardless of PRLR status. ERαKO males had 47% fewer tumors than ERα wild-type males (P < 0.01). On the other hand, estradiol treatment protected against tumorigenesis in males only in the presence of ERα. As evidenced by liver gene expression, lack of ERα did not alter the pattern of GH secretion in males but resulted in the male GH pattern in females. These observations indicate that ERα is not required for lower tumorigenesis in females, but it is required for the protective effects of exogenously delivered estradiol. Unexpectedly, the results indicate that ERα plays a role in promotion of liver tumors in males. In addition, it can be concluded that sex differences in liver tumorigenesis cannot be explained by the sexually dimorphic pattern of GH secretion. The results also rule out PRL as the mediator of the protective effect of the ovaries.
authors: Department of Obstetrics and Gynecology, Indiana University School of Medicine, 975 West Walnut Street, Indianapolis, IN 46202-5121, USA. rbigsby@iupui.edu
authors: Robert M
authors: RM
authors: Bigsby
authors: Andrea
authors: A
authors: Caperell-Grant
references: Biochem Biophys Res Commun. 1999 Nov 19;265(2):569-71
references: 10558910
references: Cancer Res. 2003 Aug 15;63(16):4914-9
references: 12941815
references: Jpn J Cancer Res. 2001 Mar;92(3):249-56
references: 11267934
references: J Biol Chem. 2001 Sep 21;276(38):35444-9
references: 11457856
references: J Endocrinol. 2001 Nov;171(2):229-36
references: 11691642
references: Carcinogenesis. 1993 May;14(5):1035-40
references: 8099313
references: Science. 2007 Jul 6;317(5834):121-4
references: 17615358
references: Recent Prog Horm Res. 1997;52:185-213; discussion 213-4
references: 9238853
references: Carcinogenesis. 2001 Nov;22(11):1853-62
references: 11698349
references: Oncology. 2010 Jul;78 Suppl 1:172-9
references: 20616601
references: Endocr Rev. 2006 Apr;27(2):101-40
references: 16434512
references: J Immunol. 1999 Jul 15;163(2):576-82
references: 10395643
references: Proc Soc Exp Biol Med. 1998 Jan;217(1):45-52
references: 9421206
references: Genes Dev. 1997 Jan 15;11(2):167-78
references: 9009200
references: Carcinogenesis. 1996 Feb;17(2):191-6
references: 8625437
references: Curr Pharm Des. 1998 Feb;4(1):71-92
references: 10197034
references: Hum Mol Genet. 2005 Apr 15;14 Spec No 1:R149-55
references: 15809267
references: Gastroenterology. 2004 Nov;127(5 Suppl 1):S72-8
references: 15508106
references: Mol Cell Biochem. 1997 Dec;177(1-2):97-105
references: 9450650
references: Tumori. 1995 Sep-Oct;81(5):351-3
references: 8804452
references: Hepatology. 2007 Oct;46(4):1304-5
references: 17896415
references: J Biol Chem. 1999 Mar 12;274(11):7421-30
references: 10066807
references: Proc Natl Acad Sci U S A. 1993 Dec 1;90(23):11162-6
references: 8248223
references: Am J Epidemiol. 2002 Feb 15;155(4):323-31
references: 11836196
references: J Neurosci. 2001 Mar 15;21(6):2085-93
references: 11245692
references: Cancer Lett. 2002 May 28;179(2):113-9
references: 11888665
references: Ann N Y Acad Sci. 2006 Nov;1089:262-7
references: 17261773
references: Alcohol. 2000 Nov;22(3):123-7
references: 11163119
references: Gastroenterology. 2004 Nov;127(5 Suppl 1):S35-50
references: 15508101
references: Endocr Rev. 2008 Feb;29(1):1-41
references: 18057139
references: Mol Pharmacol. 1999 Sep;56(3):473-7
references: 10462534
references: Proc Natl Acad Sci U S A. 1989 Oct;86(19):7505-9
references: 2798421
references: Cell. 2005 Jul 1;121(7):977-90
references: 15989949
references: Toxicology. 2006 Feb 15;219(1-3):97-105
references: 16377053
references: Arterioscler Thromb Vasc Biol. 2000 Jul;20(7):1817-23
references: 10894823
references: Jpn J Clin Oncol. 2006 Jul;36(7):445-56
references: 16782973
references: Int J Oncol. 2001 Mar;18(3):623-8
references: 11179496
references: J Clin Endocrinol Metab. 1998 May;83(5):1797-800
references: 9589695
references: Hepatology. 2004 Dec;40(6):1361-9
references: 15565568
references: Environ Health Perspect. 2000 Oct;108(10):973-7
references: 11049819
references: Proc Natl Acad Sci U S A. 1996 Jun 11;93(12):5848-53
references: 8650181
references: Mol Endocrinol. 2008 Aug;22(8):1962-74
references: 18483176
references: J Clin Endocrinol Metab. 1997 Dec;82(12):4258-65
references: 9398750
references: World J Gastroenterol. 2007 Aug 28;13(32):4295-305
references: 17708600
references: Invest Ophthalmol Vis Sci. 2009 Jul;50(7):3304-10
references: 19255148
references: Carcinogenesis. 2009 May;30(5):879-85
references: 19255062
references: Endocr Relat Cancer. 1999 Jun;6(2):315-24
references: 10731125
references: Prog Clin Biol Res. 1995;391:187-94
references: 8532716
references: Cancer Epidemiol Biomarkers Prev. 2008 Apr;17(4):846-54
references: 18398026
references: DNA Cell Biol. 1998 Sep;17(9):761-70
references: 9778035
references: J Hepatol. 2008 Feb;48(2):380-1
references: 18093689
references: J Biol Chem. 2007 Apr 20;282(16):11732-41
references: 17317669
references: Endocrinology. 2008 Dec;149(12):6198-206
references: 18719025
references: Proc Natl Acad Sci U S A. 2006 Jul 11;103(28):10544-51
references: 16807293
references: Cancer. 1996 Feb 15;77(4):635-9
references: 8616754
references: J Hepatol. 2005 Feb;42(2):218-24
references: 15664247
references: Proc Natl Acad Sci U S A. 1996 Jun 11;93(12):5925-30
references: 8650195
references: Drug Metab Pharmacokinet. 2006 Feb;21(1):29-36
references: 16547391
references: Br J Cancer. 1995 Jul;72(1):17-21
references: 7599048
references: Cancer Res. 2003 Aug 15;63(16):5041-5
references: 12941832
references: Endocrinology. 1997 May;138(5):1780-6
references: 9112368
references: Gastroenterology. 2004 Nov;127(5 Suppl 1):S27-34
references: 15508094
references: J Natl Cancer Inst. 2000 Dec 20;92(24):2023-8
references: 11121465
references: BMC Neurosci. 2010 Mar 17;11:39
references: 20236508